WE‐C‐BRA‐08: Using 4DCT‐Based Ventilation Imaging to Correlate Lung Dose and Function with Clinical Outcomes

Y. Vinogradskiy, R. Castillo, E. Castillo, S. Tucker, L. Zhongxing, T. Guerrero, M. Martel

Research output: Contribution to journalArticle

Abstract

Purpose: An exciting form of ventilation imaging is being developed based on 4‐dimensional computed tomography (4DCT) data. Because 4DCTs are routine for thoracic radiation therapy, calculating ventilation maps from 4DCT data does not add extra dosimetric or monetary cost. Studies have discussed designing treatment plans to avoid highly‐ventilated areas of the lung. However, the hypothesis that using ventilation in treatment planning can reduce thoracic toxicity remains to be tested. The purpose of our work was to determine whether incorporating ventilation‐based functional information could improve prediction for clinical thoracic toxicity. Methods: The study used 96 lung cancer patients, 17 of whom developed radiation pneumonitis (CTCAE 3.0 Grade>=3). Pre‐treatment 4DCT data, spatial registration, and a density‐change based model were used to compute pre‐treatment ventilation maps for each patient. Using dose and ventilation, we calculated dose‐volume and dose‐function histograms, mean lung doses (MLD), and ventilation‐weighted MLD (fMLD). The ventilation‐weighted dosimetric values were compared between the pneumonitis group and the non‐pneumonitis group using a two‐sample t‐test. The ventilation‐based functional data were incorporated into a predictive dose‐response model and maximum likelihood was used to determine whether incorporating functional data could significantly improve the model fit to clinical toxicity data. Results: Specific patient examples illustrate that using functional dose metrics can lead to better estimates of toxicity. The fMLD was higher for patients that developed pneumonitis (20.8 Gy) than for those that did not (18.9 Gy), however, the results were not significant (p=0.251). Although fMLD improved model fit over using MLD, the difference in fits was not found to be significant (p=0.312). Conclusions: This is the first study that has attempted to link irradiating ventilated portions of the lung to clinical outcomes. Although promising data were presented, the results were not statistically significant. Future work will include more patients and further functional information with perfusion imaging.

Original languageEnglish (US)
Number of pages1
JournalMedical Physics
Volume39
Issue number6
DOIs
StatePublished - 2012
Externally publishedYes

Fingerprint

Ventilation
Lung
Thorax
Tomography
Pneumonia
Radiation Pneumonitis
Perfusion Imaging
Lung Neoplasms
Radiotherapy
Costs and Cost Analysis
Therapeutics

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

Vinogradskiy, Y., Castillo, R., Castillo, E., Tucker, S., Zhongxing, L., Guerrero, T., & Martel, M. (2012). WE‐C‐BRA‐08: Using 4DCT‐Based Ventilation Imaging to Correlate Lung Dose and Function with Clinical Outcomes. Medical Physics, 39(6). https://doi.org/10.1118/1.4736113

WE‐C‐BRA‐08 : Using 4DCT‐Based Ventilation Imaging to Correlate Lung Dose and Function with Clinical Outcomes. / Vinogradskiy, Y.; Castillo, R.; Castillo, E.; Tucker, S.; Zhongxing, L.; Guerrero, T.; Martel, M.

In: Medical Physics, Vol. 39, No. 6, 2012.

Research output: Contribution to journalArticle

Vinogradskiy, Y, Castillo, R, Castillo, E, Tucker, S, Zhongxing, L, Guerrero, T & Martel, M 2012, 'WE‐C‐BRA‐08: Using 4DCT‐Based Ventilation Imaging to Correlate Lung Dose and Function with Clinical Outcomes', Medical Physics, vol. 39, no. 6. https://doi.org/10.1118/1.4736113
Vinogradskiy, Y. ; Castillo, R. ; Castillo, E. ; Tucker, S. ; Zhongxing, L. ; Guerrero, T. ; Martel, M. / WE‐C‐BRA‐08 : Using 4DCT‐Based Ventilation Imaging to Correlate Lung Dose and Function with Clinical Outcomes. In: Medical Physics. 2012 ; Vol. 39, No. 6.
@article{ac012ff7ed3b45779517d12e21c01409,
title = "WE‐C‐BRA‐08: Using 4DCT‐Based Ventilation Imaging to Correlate Lung Dose and Function with Clinical Outcomes",
abstract = "Purpose: An exciting form of ventilation imaging is being developed based on 4‐dimensional computed tomography (4DCT) data. Because 4DCTs are routine for thoracic radiation therapy, calculating ventilation maps from 4DCT data does not add extra dosimetric or monetary cost. Studies have discussed designing treatment plans to avoid highly‐ventilated areas of the lung. However, the hypothesis that using ventilation in treatment planning can reduce thoracic toxicity remains to be tested. The purpose of our work was to determine whether incorporating ventilation‐based functional information could improve prediction for clinical thoracic toxicity. Methods: The study used 96 lung cancer patients, 17 of whom developed radiation pneumonitis (CTCAE 3.0 Grade>=3). Pre‐treatment 4DCT data, spatial registration, and a density‐change based model were used to compute pre‐treatment ventilation maps for each patient. Using dose and ventilation, we calculated dose‐volume and dose‐function histograms, mean lung doses (MLD), and ventilation‐weighted MLD (fMLD). The ventilation‐weighted dosimetric values were compared between the pneumonitis group and the non‐pneumonitis group using a two‐sample t‐test. The ventilation‐based functional data were incorporated into a predictive dose‐response model and maximum likelihood was used to determine whether incorporating functional data could significantly improve the model fit to clinical toxicity data. Results: Specific patient examples illustrate that using functional dose metrics can lead to better estimates of toxicity. The fMLD was higher for patients that developed pneumonitis (20.8 Gy) than for those that did not (18.9 Gy), however, the results were not significant (p=0.251). Although fMLD improved model fit over using MLD, the difference in fits was not found to be significant (p=0.312). Conclusions: This is the first study that has attempted to link irradiating ventilated portions of the lung to clinical outcomes. Although promising data were presented, the results were not statistically significant. Future work will include more patients and further functional information with perfusion imaging.",
author = "Y. Vinogradskiy and R. Castillo and E. Castillo and S. Tucker and L. Zhongxing and T. Guerrero and M. Martel",
year = "2012",
doi = "10.1118/1.4736113",
language = "English (US)",
volume = "39",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - WE‐C‐BRA‐08

T2 - Using 4DCT‐Based Ventilation Imaging to Correlate Lung Dose and Function with Clinical Outcomes

AU - Vinogradskiy, Y.

AU - Castillo, R.

AU - Castillo, E.

AU - Tucker, S.

AU - Zhongxing, L.

AU - Guerrero, T.

AU - Martel, M.

PY - 2012

Y1 - 2012

N2 - Purpose: An exciting form of ventilation imaging is being developed based on 4‐dimensional computed tomography (4DCT) data. Because 4DCTs are routine for thoracic radiation therapy, calculating ventilation maps from 4DCT data does not add extra dosimetric or monetary cost. Studies have discussed designing treatment plans to avoid highly‐ventilated areas of the lung. However, the hypothesis that using ventilation in treatment planning can reduce thoracic toxicity remains to be tested. The purpose of our work was to determine whether incorporating ventilation‐based functional information could improve prediction for clinical thoracic toxicity. Methods: The study used 96 lung cancer patients, 17 of whom developed radiation pneumonitis (CTCAE 3.0 Grade>=3). Pre‐treatment 4DCT data, spatial registration, and a density‐change based model were used to compute pre‐treatment ventilation maps for each patient. Using dose and ventilation, we calculated dose‐volume and dose‐function histograms, mean lung doses (MLD), and ventilation‐weighted MLD (fMLD). The ventilation‐weighted dosimetric values were compared between the pneumonitis group and the non‐pneumonitis group using a two‐sample t‐test. The ventilation‐based functional data were incorporated into a predictive dose‐response model and maximum likelihood was used to determine whether incorporating functional data could significantly improve the model fit to clinical toxicity data. Results: Specific patient examples illustrate that using functional dose metrics can lead to better estimates of toxicity. The fMLD was higher for patients that developed pneumonitis (20.8 Gy) than for those that did not (18.9 Gy), however, the results were not significant (p=0.251). Although fMLD improved model fit over using MLD, the difference in fits was not found to be significant (p=0.312). Conclusions: This is the first study that has attempted to link irradiating ventilated portions of the lung to clinical outcomes. Although promising data were presented, the results were not statistically significant. Future work will include more patients and further functional information with perfusion imaging.

AB - Purpose: An exciting form of ventilation imaging is being developed based on 4‐dimensional computed tomography (4DCT) data. Because 4DCTs are routine for thoracic radiation therapy, calculating ventilation maps from 4DCT data does not add extra dosimetric or monetary cost. Studies have discussed designing treatment plans to avoid highly‐ventilated areas of the lung. However, the hypothesis that using ventilation in treatment planning can reduce thoracic toxicity remains to be tested. The purpose of our work was to determine whether incorporating ventilation‐based functional information could improve prediction for clinical thoracic toxicity. Methods: The study used 96 lung cancer patients, 17 of whom developed radiation pneumonitis (CTCAE 3.0 Grade>=3). Pre‐treatment 4DCT data, spatial registration, and a density‐change based model were used to compute pre‐treatment ventilation maps for each patient. Using dose and ventilation, we calculated dose‐volume and dose‐function histograms, mean lung doses (MLD), and ventilation‐weighted MLD (fMLD). The ventilation‐weighted dosimetric values were compared between the pneumonitis group and the non‐pneumonitis group using a two‐sample t‐test. The ventilation‐based functional data were incorporated into a predictive dose‐response model and maximum likelihood was used to determine whether incorporating functional data could significantly improve the model fit to clinical toxicity data. Results: Specific patient examples illustrate that using functional dose metrics can lead to better estimates of toxicity. The fMLD was higher for patients that developed pneumonitis (20.8 Gy) than for those that did not (18.9 Gy), however, the results were not significant (p=0.251). Although fMLD improved model fit over using MLD, the difference in fits was not found to be significant (p=0.312). Conclusions: This is the first study that has attempted to link irradiating ventilated portions of the lung to clinical outcomes. Although promising data were presented, the results were not statistically significant. Future work will include more patients and further functional information with perfusion imaging.

UR - http://www.scopus.com/inward/record.url?scp=85024783721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024783721&partnerID=8YFLogxK

U2 - 10.1118/1.4736113

DO - 10.1118/1.4736113

M3 - Article

AN - SCOPUS:85024783721

VL - 39

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -